Hopp til innhold
NHI.no
Annonse

Kardiomyopati, svangerskapsrelatert: Behandling

Innhold i artikkelen

Siden årsaken er ukjent, finnes det ingen underliggende sykdom som kan behandles. Behandlingen er som ved hjertesvikt av andre årsaker. Medikamenter som betablokkere, ACE-hemmere og vanndrivende medisiner brukes. Dersom det blir nødvendig med behandling før barnet er født, er det flere medikamentgrupper som ikke kan brukes fordi de kan skade barnet (eks. ACE.hemmere). Vanlig behandlingstid er minst 1 år. I alvorlige tilfeller kan det bli aktuelt med hjertetransplantasjon.

Annonse

Forøvrig bør du være forsiktig med bruk av for mye salt og alkoholinntak må begrenses. 

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Kardiomyopati, peripartum . Referanselisten for dette dokumentet vises nedenfor

  1. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010; 12: 767. pmid:20675664 PubMed
  2. Elliot P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008; 29: 270-6. European Heart Journal
  3. Baris L, Cornette J, Johnson MR, et al. Peripartum cardiomyopathy: disease or syndrome?. Heart 2019; 105: 357-62. doi:10.1136/heartjnl-2018-314252 DOI
  4. Ersbøll AS , Johansen M , Damm P , et al . Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. Eur J Heart Fail 2017;19:1712–20. PMID: 28597481 PubMed
  5. Kolte D, Khera S, Aronom WS, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 2014; 3: E001056. pmid:24901108 PubMed
  6. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006; 368: 687-93. PubMed
  7. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010; 121: 2169. Circulation
  8. Christiansen MN, Køber L, Torp-Pedersen C, et al. Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy. Heart 2019; 105: 1057-62. pmid:30910822 PubMed
  9. van Spaendonck-Zwarts KY , Posafalvi A , van den Berg MP , et al . Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 2014;35:2165–73. PMID: 24558114 PubMed
  10. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy. National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop recommendations and review. JAMA 2000; 283: 1183-8. Journal of the American Medical Association
  11. Sliwa K, Forster O, Libhaber E et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441-6. European Heart Journal
  12. Fett JD, Carraway RD, Dowell DL, King ME and Pierre R. Periptum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 2002; 186: 1005-10. PubMed
  13. Elkayam U, Akhter MW, Singh HS, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050-5. Circulation
  14. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999; 94: 311-6. PubMed
  15. Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010; 121: 1465. Circulation
  16. Phillips SD and Warnes CA. Peripartum cardiomyopathy: current therapeutic perspectives. Curr Treat Options Cardiovasc Med 2004; 6: 481-8. PubMed
  17. Mallikethi-Reddy S, Akintoye E, Trehan N, et al. Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations. Int J Cardiol 2017; 235: 114. pmid:28268089 PubMed
  18. Felkner GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-84. New England Journal of Medicine
  19. Elkayam U, Padmini P, Tummala P, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001; 344: 1567-71. New England Journal of Medicine
  20. Fett JD, Christie LG and Murphy JG. Outcome of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Int Med 2006; 145: 30-4. PubMed
Annonse
Annonse